Advanced Medical Solutions Group (LON:AMS) Given “Buy” Rating at Berenberg Bank

Advanced Medical Solutions Group (LON:AMS)‘s stock had its “buy” rating reissued by equities researchers at Berenberg Bank in a research report issued on Tuesday, MarketBeat Ratings reports. They currently have a GBX 300 ($3.67) price target on the stock. Berenberg Bank’s price objective suggests a potential upside of 33.33% from the company’s current price.

Advanced Medical Solutions Group Price Performance

Advanced Medical Solutions Group stock opened at GBX 225 ($2.75) on Tuesday. The firm has a market capitalization of £482.74 million, a P/E ratio of 4,500.00, a PEG ratio of 5.00 and a beta of 0.74. Advanced Medical Solutions Group has a 1 year low of GBX 176.60 ($2.16) and a 1 year high of GBX 275.83 ($3.38). The business has a 50-day moving average of GBX 204.11 and a 200-day moving average of GBX 220.21. The company has a current ratio of 8.39, a quick ratio of 4.58 and a debt-to-equity ratio of 37.01.

Insider Transactions at Advanced Medical Solutions Group

In other news, insider Eddie Johnson sold 34,235 shares of Advanced Medical Solutions Group stock in a transaction dated Monday, November 11th. The stock was sold at an average price of GBX 218 ($2.67), for a total transaction of £74,632.30 ($91,349.20). Corporate insiders own 3.12% of the company’s stock.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.